Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2851 AL 2865

The Twofold Role of Osteogenic Small Molecules in Parkinson's Disease Therapeutics: Crosstalk of Osteogenesis and Neurogenesis

Tavakol S.

Biomed Res Int. 2022 Dec 12;2022:3813541. doi: 10.1155/2022/3813541. eCollection 2022.

A review on the role of miR-671 in human disorders

Ghafouri-Fard S, Askari A, Hussen BM, Rasul MF, Hatamian S, Taheri M, Kiani A.

Front Mol Biosci. 2022 Dec 5;9:1077968. doi: 10.3389/fmolb.2022.1077968. eCollection 2022.

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors

Lattanzi R, Miele R.

Curr Issues Mol Biol. 2022 Dec 12;44(12):6323-6332. doi: 10.3390/cimb44120431.

Relevance of Fluorodopa PET Scan in Dopamine Responsive Dystonia and Juvenile Parkinsonism: A Systematic Review

Moncayo JA, Vargas M, Ortiz JF, Granda P, Aguirre AS, Argudo J, Tambo W, Garofalo G, Capirig CJ, German-Montenegro M, Rueda LG.

Neurol Int. 2022 Dec 2;14(4):997-1006. doi: 10.3390/neurolint14040079.

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases

Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L.

Biosensors (Basel). 2022 Nov 24;12(12):1074. doi: 10.3390/bios12121074.

A Focus on Astrocyte Contribution to Parkinson's Disease Etiology

Prunell G, Olivera-Bravo S.

Biomolecules. 2022 Nov 24;12(12):1745. doi: 10.3390/biom12121745.

Advances in Gene Therapy Techniques to Treat LRRK2 Gene Mutation

Chung SK, Lee SY.

Biomolecules. 2022 Dec 5;12(12):1814. doi: 10.3390/biom12121814.

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

Vuic B, Milos T, Tudor L, Konjevod M, Nikolac Perkovic M, Jazvinscak Jembrek M, Nedic Erjavec G, Svob Strac D.

Biomedicines. 2022 Nov 22;10(12):3000. doi: 10.3390/biomedicines10123000.

How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review

Zhang TD, Kolbe SC, Beauchamp LC, Woodbridge EK, Finkelstein DI, Burrows EL.

Biomedicines. 2022 Nov 24;10(12):3026. doi: 10.3390/biomedicines10123026.

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders

Karaki T, Haniu H, Matsuda Y, Tsukahara T.

Biomedicines. 2022 Dec 3;10(12):3126. doi: 10.3390/biomedicines10123126.

Anderson-Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?

Zedde M, Pascarella R, Cavallieri F, Pezzella FR, Grisanti S, Di Fonzo A, Valzania F.

Biomedicines. 2022 Dec 5;10(12):3132. doi: 10.3390/biomedicines10123132.

Exercise-Boosted Mitochondrial Remodeling in Parkinson's Disease

Magaña JC, Deus CM, Giné-Garriga M, Montané J, Pereira SP.

Biomedicines. 2022 Dec 12;10(12):3228. doi: 10.3390/biomedicines10123228.

Synucleins: New Data on Misfolding, Aggregation and Role in Diseases

Surguchov A, Surguchev A.

Biomedicines. 2022 Dec 13;10(12):3241. doi: 10.3390/biomedicines10123241.

Cannabinoids in Late Life Parkinson's Disease and Dementia: Biological Pathways and Clinical Challenges

Costa AC, Joaquim HPG, Pedrazzi JFC, Pain AO, Duque G, Aprahamian I.

Brain Sci. 2022 Nov 22;12(12):1596. doi: 10.3390/brainsci12121596.

The Interrelated Multifactorial Actions of Cortisol and Klotho: Potential Implications in the Pathogenesis of Parkinson's Disease

Luthra NS, Clow A, Corcos DM.

Brain Sci. 2022 Dec 10;12(12):1695. doi: 10.3390/brainsci12121695.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias